Kansas City Cardiomyopathy Questionnaire total symptom score
1 paper
- Human trial1
Latest
2 in 12 monthsPLOS One
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study
Non-randomised trial in 7 peopleDapagliflozin
AHA Scientific Sessions 2025 Abstract
Survodutide for the Treatment of Obesity: Baseline characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial
Trial in peopleInterventions